• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Decreased incidence, virus transmission capacity, and severity of COVID-19 at altitude on the American continent

tetano

Editor, Senior Moderator
PLoS One


. 2021 Mar 29;16(3):e0237294.
doi: 10.1371/journal.pone.0237294. eCollection 2021.
Decreased incidence, virus transmission capacity, and severity of COVID-19 at altitude on the American continent


Christian Arias-Reyes[SUP] 1 [/SUP], Favio Carvajal-Rodriguez[SUP] 1 [/SUP], Liliana Poma-Machicao[SUP] 1 [/SUP], Fernanda Aliaga-Radu?n[SUP] 1 [/SUP], Danuzia A Marques[SUP] 1 [/SUP], Natalia Zubieta-DeUrioste[SUP] 2 [/SUP], Roberto Alfonso Accinelli[SUP] 3 [/SUP], Edith M Schneider-Gasser[SUP] 4 [/SUP], Gustavo Zubieta-Calleja[SUP] 2 [/SUP], Mathias Dutschmann[SUP] 5 [/SUP], Jorge Soliz[SUP] 1 2 [/SUP]



Affiliations

Abstract

The coronavirus disease 2019 (COVID-19) outbreak in North, Central, and South America has become the epicenter of the current pandemic. We have suggested previously that the infection rate of this virus might be lower in people living at high altitude (over 2,500 m) compared to that in the lowlands. Based on data from official sources, we performed a new epidemiological analysis of the development of the pandemic in 23 countries on the American continent as of May 23, 2020. Our results confirm our previous finding, further showing that the incidence of COVID-19 on the American continent decreases significantly starting at 1,000 m above sea level (masl). Moreover, epidemiological modeling indicates that the virus transmission rate is lower in the highlands (>1,000 masl) than in the lowlands (<1,000 masl). Finally, evaluating the differences in the recovery percentage of patients, the death-to-case ratio, and the theoretical fraction of undiagnosed cases, we found that the severity of COVID-19 is also decreased above 1,000 m. We conclude that the impact of the COVID-19 decreases significantly with altitude.
 
Back
Top Bottom